CliffBio
small molecule

ACIPHEX SPRINKLE

RABEPRAZOLE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyAYTU BIOSCIENCE INC

Drug detail

Brand nameACIPHEX SPRINKLE
Active ingredientRABEPRAZOLE SODIUM
Strength10MG
Dosage formCAPSULE, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2013
Marketing statusDISCN

More from AYTU BIOSCIENCE INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ACIPHEX SPRINKLE patent cliff — loss of exclusivity — | CliffBio